| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Total Income - EUR | - | - | 0 | 353 | 4.611 | 5.557 | 5.434 | 3.423 | - | - |
| Total Expenses - EUR | - | - | 251 | 12.639 | 20.432 | 20.248 | 6.289 | 5.324 | - | - |
| Gross Profit/Loss - EUR | - | - | -251 | -12.287 | -15.821 | -14.690 | -855 | -1.900 | - | - |
| Net Profit/Loss - EUR | - | - | -251 | -12.287 | -15.821 | -14.690 | -855 | -1.900 | - | - |
| Employees | - | - | 0 | 2 | 2 | 2 | 1 | 0 | - | - |
Check the financial reports for the company - Natural Bio Technologies Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1 | 35.285 | 28.567 | 21.865 | 15.474 | 10.408 | - | - |
| Current Assets | - | - | 59 | 1.583 | 5.811 | 380 | 229 | 234 | - | - |
| Inventories | - | - | 0 | 0 | 0 | 154 | 151 | 151 | - | - |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Cash | - | - | 59 | 1.583 | 5.811 | 226 | 79 | 83 | - | - |
| Shareholders Funds | - | - | -207 | -12.490 | -28.025 | -42.184 | -42.104 | -44.135 | - | - |
| Social Capital | - | - | 44 | 43 | 86 | 85 | 83 | 83 | - | - |
| Debts | - | - | 267 | 6.788 | 19.963 | 28.345 | 27.947 | 28.247 | - | - |
| Income in Advance | - | - | 0 | 42.626 | 42.458 | 36.095 | 29.861 | 26.530 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1089 - 1089" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Natural Bio Technologies Srl